Showing 811-820 of 951 results for "".
- Editor's Messagehttps://practicalneurology.com/columns/practice-management/editors-message/31050/Deep Brain Stimulation (DBS) Uncovers Potential in Memory RestorationA recent groundbreaking study published in the *Annals of Neurology* has highlighted the unexpected capabilities of Deep Brain Stimulation (DBS) in enhancing memory retention. Traditionally utilized for managing movement disorders
- Advancements in Epilepsy Syndrome Diagnosis and Managementhttps://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/pn0208-epilepsy-dept-pdf/31051/Advancements in Epilepsy Syndrome Diagnosis and ManagementEpilepsy, one of the most historically recognized neurological disorders, remains the second most prevalent neurological condition, affecting approximately one percent of the global population. In the United States and Europe, new epilepsy ca
- Editor's Messagehttps://practicalneurology.com/columns/practice-management/editors-message/31062/Practical Neurology continues to serve as a vital resource for healthcare professionals in the neurology field, emphasizing both clinical excellence and effective practice management. In the January 2008 issue, Editor-in-Chief Jack Persico highlights the critical importance of communication between
- Editor's Messagehttps://practicalneurology.com/columns/practice-management/editors-message/31077/In the December 2007 issue of Practical Neurology, Editor-in-Chief Jack Persico draws a poignant parallel between the classic film "It's a Wonderful Life" and the current state of neurology practice. Highlighting an article by Dr. Ronald DeVere, the discussion focuses on the pervasive issue of physi
- Vascular Clinichttps://practicalneurology.com/columns/practice-management/vascular-clinic/31087/Establishing a successful hospital-based stroke program critically depends on unwavering support from hospital administration, a key requirement for Joint Commission on Accreditation of Healthcare Organizations (JCAHO) primary stroke center certification. In his December 2007 article for Practical N
- Coping with MS: How to Give Patients Their Lives Backhttps://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/pn0907-ms-feature-pdf/31123/Comprehensive Symptom Management in Multiple SclerosisMultiple sclerosis (MS) encompasses a wide range of symptoms beyond demyelination, requiring a holistic approach to patient care. Effective management focuses on both direct neurological impairments and the myriad of ancillary symptoms that affec
- What Should We Do About Asymptomatic AVMs?https://practicalneurology.com/columns/practice-management/what-should-we-do-about-asymptomatic-avms/31127/Clinical Decision-Making in the Management of Asymptomatic Cerebral Arteriovenous MalformationsCerebral arteriovenous malformations (AVMs) present a significant clinical challenge, especially when asymptomatic. The primary dilemma revolves around balancing the natural hemorrhage risk against the pot
- News Briefshttps://practicalneurology.com/columns/practice-management/news-briefs/31137/Clinical Insights: Recent Advances in NeurologyRecent genetic studies continue to illuminate the complex interplay between genetics and multiple sclerosis (MS). A genome-wide association study published in the *New England Journal of Medicine* identified heritable risk factors for MS, specifically a
- Therapeutics Q&Ahttps://practicalneurology.com/columns/practice-management/therapeutics-qa/31140/Impact of SSRIs on Bone Health in Elderly Patients: Clinical InsightsRecent studies have raised concerns about the use of selective serotonin reuptake inhibitors (SSRIs) and their potential negative effects on bone health in older adults. These findings pose important considerations for neurologists
- Levodopa: Life Begins at 40?https://practicalneurology.com/columns/practice-management/levodopa-life-begins-at-40/31189/Levodopa Remains Cornerstone in Parkinson’s Disease Therapy After 40 YearsForty years after the seminal 1967 Cotzias study, levodopa continues to be the primary treatment for Parkinson’s disease (PD), underscoring its enduring efficacy in managing motor symptoms. Levodopa’s journey from a laboratory